Intranasal Insulin for Autism in Children and Young Adults
Part of Mental health clinical trials.
This study observes how intranasal insulin (a form of insulin delivered through the nose) affects children and young adults with autism spectrum disorder who are already using or planning to use it as part of their regular care. Researchers will track changes in behavior and social skills over about 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 4 and 21 years old
- Your child has a clinical diagnosis of autism spectrum disorder confirmed by a healthcare provider
- Your child is currently using intranasal insulin or planning to start it as prescribed by their doctor
- Any current medical or behavioral treatments have been stable for at least 4 weeks
- You (parent or guardian) can give informed consent and complete study questionnaires over 6 months
- Your child does not have diabetes, recurrent low blood sugar, or a known allergy to insulin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral liquid medicine (called NTI164) to see if it helps reduce symptoms of autism in children and teens. It may be an option if current treatments haven't fully helped, but it requires regular study visits and certain health rules.
This trial tests whether adding oxytocin nasal spray to standard behavioral therapy can help reduce challenging behaviors in children with autism and intellectual disability. It aims to see if the treatment is safe and practical.
This Phase 2 study tests whether oxytocin can help improve bone health in children and teens with autism spectrum disorder. It also checks safety by monitoring symptoms and doing blood tests and imaging.
This trial tests if the steroid prednisone can help adults with moderate-to-severe autism who also have signs of immune system problems, like autoimmune disease or inflammation. It might offer a new treatment option for people whose autism is linked to immune activity.
This study tests three special diets (low glycemic index, modified Atkins, and gluten-free/casein-free) as add-ons to usual care for children aged 3-8 with autism. The goal is to see if any of these diets can improve autism symptoms.
This trial tests if exosomes from stem cells can help children with autism who haven't improved enough with standard behavioral therapy. It aims to see if this treatment is safe and effective for reducing autism symptoms.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.